Four session leaders at this year's ABRF meeting shared the discussions that arose in their sessions and the tech that interested them most.

In this issue of BioTechniques, we present data from a validation study of a software tool for use in forensic investigative genetic genealogy and a method for producing hydrogel-based ‘transparent ...

A bioactive compound produced by an extremophilic bacterium has potential industrial applications. An international collaboration of researchers has isolated a bioactive compound in extremophilic ...

Researchers have discovered a new disease-causing ALS gene in individuals from a small region of Spain, opening the door to improved diagnostics and potential treatments.

This short video introduces antimicrobial resistance (AMR) and highlights how Oxford Nanopore technology can resolve whole bacterial genomes to find AMR genes within hours. This rapid identification ...

In this issue of BioTechniques, we present a novel method for sampling subgingival microbiome, a comparison of three methods for extracting genomic DNA from the shoots of four Dendrocalamus species, ...

A new class of drug delivery platforms has been developed from engineering amyloid beta peptides, which are present in Alzheimer's disease.

In this issue of BioTechniques, we present a comparison of four analytical methods for hydrogen sulfide quantification and a method for targeted cell delivery to a hydrogel support structure that can ...

One of the largest genome-wide studies to date has brought researchers a TAD closer to understanding the genetic factors contributing to autism. Autism spectrum disorder (ASD) is a collection of ...

CD4+ T-cells, primarily considered to play a supportive role in the anti-tumor immune response, have now been shown to pack a punch in a mouse model of melanoma.

Scientists have developed a drinkable, carbon monoxide-infused foam that impacts autophagy in cancerous cells, reducing tumor volumes.

Researchers develop a computational model to predict sgRNA efficiency and optimize gene editing with CRISPR/Cas9.